These small cap ASX shares can rise 30% to 80%: Bell Potter

Its analysts see huge upside potential for these small caps from current levels.

| More on:
A man in his office leans back in his chair with his hands behind his head looking out his window at the city, sitting back and relaxed, confident in his ASX share investments for the long term.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

There could be some very big returns on offer at the small side of the market according to analysts at Bell Potter.

For example, the broker has just reaffirmed its buy ratings on small cap ASX shares Genetic Signatures Ltd (ASX: GSS) and Clarity Pharmaceuticals Ltd (ASX: CU6).

In respect to Genetic Signatures, it is a molecular diagnostics company focused on the development and commercialisation of its proprietary platform technology, 3base. It is used to improve the diagnosis of infectious diseases.

Why is it a small cap ASX share to buy?

Bell Potter notes that the small cap recently conducted a $15.9 million capital raising. This will be used to support a commercial launch in the United States. It believes this leaves the company well-positioned to hit the ground running if the FDA approves its product. It said:

GSS are in the process of providing Additional Information to the FDA following a 60- day Substantive Review of the GI Parasite Detection Kit, a normal course of proceedings for 510(k) applications such as this. We remain confident in the likelihood of clearance, most likely around May 2024. There are 6 US lab sites that have already installed and are evaluating the product and these labs could swiftly convert to paying customers following FDA clearance.

We had assumed an FY24 capital raise so there were only minor changes in our valuation due to the number and price of new shares issued. Valuation is now $0.80 down from $0.83. We maintain a BUY (speculative) recommendation and see positive risk-reward ahead of the major FDA catalyst. The improved balance sheet position alleviates near-term funding concerns and provides ample cash runway for FDA clearance and US sales ramp up.

Bell Potter has a speculative buy rating and 80 cents price target on its shares. This suggests a potential upside of approximately 84% for investors over the next 12 months.

Another small cap to buy

Bell Potter also believes that Clarity Pharmaceuticals shares can rise strongly from current levels.

This week, the broker put a speculative buy rating and $3.00 price target on the radiopharmaceutical company's shares. This implies a 36% upside for investors from current levels.

Its analysts are very positive on the small cap ASX share's SAR-bis-PSMA platform. It explains:

Clarity's SAR-bis-PSMA platform is emerging as a highly differentiated platform for the imaging and treatment of mCRPC. The IP protection is top shelf compared to existing platforms and combined with the emerging clinical data, we believe the company has a promising future. Earnings adjustments include increases to R&D spend over the forecast period following commencement of approval studies. Valuation is increased from $1.70 to $3.00.

Finally, it is worth highlighting that these are speculative buy ratings. This means that they may only be suitable for investors with a high tolerance for risk.

Should you invest $1,000 in Clarity Pharmaceuticals right now?

Before you buy Clarity Pharmaceuticals shares, consider this:

Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now... and Clarity Pharmaceuticals wasn't one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

And right now, Scott thinks there are 5 stocks that may be better buys...

See The 5 Stocks *Returns as of 9 January 2025

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Small Cap Shares

A group of businesspeople clapping.
Healthcare Shares

This fund returned 109% in 2024. Here are 2 of its best-performing ASX shares

Small caps proved to be the winners last year.

Read more »

A boy stands firm on a rocky cliff holding a rocket in each hand and looking up toward the sky, anticipating flying into space.
Technology Shares

2 small-cap ASX tech shares rocketing on big US news

The junior ASX tech shares are enjoying a big lift following positive developments in the US.

Read more »

A young man punches the air in delight as he reacts to great news on his mobile phone.
Small Cap Shares

Guess which ASX small-cap is up 92% in just 2 days!

Investors have been fighting to get hold of this stock this week. But why?

Read more »

Two boys looking at each other while standing by start line on stadium against two schoolgirls.
Small Cap Shares

The imminent tailwind for ASX small-cap shares: fundie

Oscar Oberg from Wilson Asset Management explains why he thinks it's a good time to buy small-caps.

Read more »

Small girl giving a fist bump with a piggy bank in front of her.
Small Cap Shares

Want more exposure to small-cap stocks? I'd invest in this ASX ETF

Small-caps can have a lot of growth potential.

Read more »

A female ASX investor looks through a magnifying glass that enlarges her eye and holds her hand to her face with her mouth open as if looking at something of great interest or surprise.
Small Cap Shares

Bell Potter says this ASX share is a 'small-cap investment opportunity'

The broker thinks this small cap is destined to deliver strong earnings growth.

Read more »

man looking happy and excited as he looks at his mobile phone
Small Cap Shares

Guess which small cap ASX stock is jumping 12% despite the market selloff

Let's find out why investors are buying this small cap today.

Read more »

Boys making faces and flexing.
Small Cap Shares

3 ASX small-cap shares that ripped 295% to 900% in 2024

Several individual small-caps shone but the S&P/ASX Small Ordinaries Index underperformed the ASX 200.

Read more »